California backs a 'fiscal cliff' compromise — sort of, poll says

As America careens toward the year-end "fiscal cliff" with Democrats pressing for tax hikes and Republicans demanding budget cuts, California voters have one firm word for their elected officials:

Compromise.

By that they mean: Make the other side compromise.

In a survey that confirms the difficulty of coming up with popular ways to do unpopular things, a USC Dornsife/Los Angeles Times poll found that 3 in 5 Californians want their elected officials to "compromise with the opposite party, even if that means giving up some long-held positions."

But things foundered on the details.

When Democrats were asked whether cuts in Medicare and Social Security benefits should be offered to get Republican agreement on some tax hikes, or whether all reductions were off the table, they strongly opposed any benefit cuts.

When Republicans were asked whether some revenue hikes should be accepted to get Democrats to agree to benefit cuts, they just as firmly opposed any tax increases.

The independent voters in the middle sided with Democrats in saying that benefits should not be sacrificed for tax hikes. Only narrowly did they say that Republicans should agree to raise taxes as part of a budget deal that would also slice benefits.

In short, the state that is often cast as far out on the fringe of the nation's political thought demonstrated that it has at least this in common with everywhere else: defining compromise as a one-way street.

"People are in favor of compromise as long as other people are doing the compromising," said David Kanevsky of the Republican firm American Viewpoint, half of a bipartisan duo that conducted the poll for The Times and the USC Dornsife College of Letters, Arts and Sciences.

The poll also confirmed the outcome of last week's election, in which President Obama won a second romping victory in California. There was broad support for the president and his campaign proposal to raise taxes on incomes over $250,000 a year.

Given a choice of three options loudly debated in the campaign, 51% of Californians said the George W. Bush administration tax cuts set to expire at the end of the year should be left in place for those making less than that amount. Only 28% took the position espoused by Republican leaders that all of the tax cuts should remain in place. A smaller group still, 17%, said everyone's taxes should be raised to help cut the nation's deficit.

"This is a difficult problem to solve, but the president's agenda came out of this in a strong position in California," said Drew Lieberman of Greenberg Quinlan Rosner Research, the Democratic poll partner of American Viewpoint.

When budget options for the fight now brewing in Washington were proposed separately, California was generally in line with voters elsewhere in the nation. Voters took a measured approach to taxes, weren't keen on cutting the defense budget and objected strenuously to cuts in social programs, Medicare and Social Security. Essentially, they endorsed the stalemate that has blocked both parties from attacking the federal deficit.

Asked whether taxes should be raised wholesale, Californians objected, 54% to 43%. Anti-tax feelings were shared by unusual bedfellows: 79% of Republicans, 65% of Latinos, 60% of those making less than $50,000 a year.

Sentiment flipped when it came to raising taxes on those making more than $250,000 a year, an option supported by 67% of respondents; 31% opposed it. Most major demographic and ideological groups, except for Republicans, strongly backed such a move. Even those most directly affected — those making more than $100,000 — favored a tax hike by a 24-percentage-point margin.

When it came to budget cuts, Californians were split on whether to cut defense spending by $600 billion, as required in the budget deal agreed to by Obama and Republicans last year. Democrats backed the cuts by almost 2 to 1, while independent voters gave it narrow support and Republicans strongly objected.

No substitute cuts passed muster, however. Seventy percent of Californians rejected replacing the defense cuts with ones to spending on education and healthcare. All major groups but Republicans shared that view; Republicans were split on domestic cuts.

Objections ran even stronger to proposed reductions in Medicare and Social Security benefits, part of the turf on which the presidential campaign was fought. At least 4 in 5 white voters, Latinos and Democrats rejected such cuts, as did 75% of Republicans and independent voters.

"You have to feel bad for voters," said poll director Dan Schnur of the Jesse M. Unruh School of Politics at USC. "After a yearlong presidential campaign, no one has bothered to tell them that raising taxes on people making over $250,000 does not balance the federal budget. No one on either side.

Read More..

France Grants Its Recognition to Syria Rebels as U.S. Waits

Javier Manzano/Agence France-Presse — Getty Images

Smoke billowed from burning tires as a Syria rebel fired towards regime forces during clashes in the Al-Amariya district of Aleppo in Syria on Tuesday.

PARIS — Syrian authorities ordered airstrikes for a third straight day close to the Turkish border on Wednesday, and said a French decision to recognize and consider arming a newly formed Syrian rebel coalition was an “immoral” act “encouraging the destruction of Syria.”

The French move represented an attempt to inject momentum into a broad Western and Arab effort to build a viable and effective opposition to hasten the end of a stalemated civil war which has destabilized the Middle East. For its part, the United States on Wednesday signaled a reluctance to go beyond its characterization of the rebel alliance as a legitimate representative of the Syrian people, rather than as their sole representative.

Speaking in Perth, Australia, Secretary of State Hillary Rodham Clinton said Washington first wanted to see the coalition influencing events on the ground.

“As the Syrian opposition takes these steps and demonstrates its effectiveness in advancing the cause of a unified, democratic, pluralistic Syria, we will be prepared to work with them to deliver assistance to the Syrian people,” news reports quoted her saying.

At the same time, she announced $30 million in American humanitarian aid to feed people affected by the civil war, bringing the total American assistance to almost $200 million.

The airstrikes on Wednesday underscored the urgency of the diplomatic maneuvers. Journalists along the 550-mile border between Turkey and Syria near the Turkish border town of Ceylanpinar said they witnessed a Syrian airstrike in the adjacent Syrian town of Ras al-Ain, where rebels say they have ousted troops loyal to Mr. Assad. It was the third such strike there in as many days.

In response, Reuters reported, Turkey scrambled fighter jets to its southeastern border with Syria, recalling Turkey’s insistence that it will not refrain from a tougher reaction against Syria.

The official SANA news agency in Syria made no direct reference to the Western moves. But the deputy foreign minister, Faisal Muqdad, told the Agence France-Presse news agency that the establishment of the opposition coalition in Doha, Qatar, was a “ declaration of war.” "We read the Doha document and they reject any dialogue with the government."

Referring to the French recognition of the alliance, he said: “Allow me to use the word, this is an immoral position. They are supporting killers, terrorists and they are encouraging the destruction of Syria.”The announcement by President François Hollande on Tuesday made France the first Western country to fully embrace the new coalition, which came together this past weekend under Western pressure after days of difficult negotiations in Doha, Qatar.

The goal was to make an opposition leadership — both inside and outside the country — representative of the array of Syrian groups pressing for the downfall of President Bashar al-Assad. Although Mr. Assad is increasingly isolated as his country descends further into mayhem and despair after 20 months of conflict, he has survived partly because of the disagreements and lack of unity among his opponents. Throughout the conflict, the West has taken half measures and been reluctant to back an aggressive effort to oust Mr. Assad. This appears to be the first time that Western nations, with Arab allies, are determined to build a viable opposition leadership that can ultimately function as a government. Whether it can succeed remains unclear.

Mr. Hollande went beyond other Western pledges of support for the new Syrian umbrella rebel group, which calls itself the National Coalition of Syrian Revolutionary and Opposition Forces. But Mr. Hollande’s announcement clearly signaled expectations that if the group can establish political legitimacy and an operational structure inside Syria, creating an alternative to the Assad family’s four decades in power, it will be rewarded with further recognition, money and possibly weapons.

“I announce that France recognizes the Syrian National Coalition as the sole representative of the Syrian people and thus as the future provisional government of a democratic Syria and to bring an end to Bashar al-Assad’s regime,” said Mr. Hollande, who has been one of the Syrian president’s harshest critics.

As for weapons, Mr. Hollande said, France had not supported arming the rebels up to now, but “with the coalition, as soon as it is a legitimate government of Syria, this question will be looked at by France, but also by all countries that recognize this government.”

The six Arab countries of the Gulf Cooperation Council, including key opposition supporters Qatar and Saudi Arabia, recognized the rebel coalition on Monday as the legitimate Syrian government. Political analysts called Mr. Hollande’s announcement an important moment in the Syrian conflict, which began as a peaceful Arab Spring uprising in March 2011. It was harshly suppressed by Mr. Assad, turned into a civil war and has left nearly 40,000 Syrians dead, displaced about 2.5 million and forced more than 400,000 to flee to neighboring countries, according to international relief agencies.

Steven Erlanger reported from Paris, Rick Gladstone from New York, and Alan Cowell from Paris. Reporting was contributed by Neil MacFarquhar and Hwaida Saad from Beirut, Lebanon; Nick Cumming-Bruce from Geneva; and Alan Cowell from Paris.

Read More..

Microsoft and Google financials could surface at trial

(Reuters) – Microsoft and Google‘s Motorola Mobility unit squared off on Tuesday at a trial with strategic implications for the smartphone patent wars and which could reveal financial information the two companies usually keep under wraps.

The proceeding in a Seattle federal court will determine how much of a royalty Microsoft Corp should pay Google Inc for a license to some of Motorola‘s patents. Google bought Motorola for $ 12.5 billion, partly for its library of communications patents.

If U.S. District Judge James Robart decides Google deserves only a small royalty, then its Motorola patents would be a weaker bargaining chip for Google to negotiate licensing deals with rivals.

Apple Inc and Microsoft have been litigating in courts around the world against Google and partners like Samsung Electronics Co Ltd, which use the Android operating system on their mobile devices.

Apple contends that Android is basically a copy of its iOS smartphone software, and Microsoft holds patents that it contends cover a number of Android features.

Motorola had sought up to $ 4 billion a year for its wireless and video patents, while Microsoft argues its rival deserves just over $ 1 million a year. A federal judge in Wisconsin last week threw out a similar case brought by Apple against Google just before trial.

In court on Tuesday Microsoft called Jon DeVaan, a veteran software manager in the Windows division, as its first witness. He said Motorola‘s wireless and video patents at issue covered only a small part of the overall Windows architecture.

During the run-up to trial in Seattle, both Microsoft and Google asked Robart to keep secret a range of financial details about the two companies, including licensing deals and sales revenue projections. Google requested that Robart clear the courtroom when witnesses discuss those details.

However, in an order on Monday, Robart rejected that request. The public will not be able to view the documents describing patent deals or company sales during trial, Robart ruled, but testimony will be in open court.

“If a witness discloses pertinent terms, rates or payments, such information will necessarily be made public,” the judge wrote.

Additionally, any documents the judge relies on for his final opinion will be disclosed, Robart wrote on Monday.

Before trial began on Tuesday, Robart said in court that he wanted to take the most “expansive” interpretation of the public’s right to know. Several outside companies besides Microsoft and Motorola, like Research in Motion Inc, have also asked him to keep secret their royalty deals.

Robart said he would consider a request to refer to those third party companies by code names, known only to the lawyers and the judge.

The case in U.S. District Court, Western District of Washington is Microsoft Corp. vs. Motorola Inc., 10-cv-1823.

(Reporting By Bill Rigby in Seattle and Dan Levine in San Francisco; editing by Jim Marshall and Carol Bishopric)

Wireless News Headlines – Yahoo! News

Read More..

Channing Tatum Is PEOPLE's Sexiest Man Alive!

By Antoinette Coulton and Julie Jordan

11/14/2012 at 08:00 AM EST

He may have bared (almost) all of that incredibly chiseled body in this year's Magic Mike but 2012's Sexiest Man Alive Channing Tatum was still modest when he heard the news.

"My first thought was, 'Y'all are messing with me,'" says Tatum, who married actress Jenna Dewan-Tatum in 2009. "I told Jenna after we'd been in the bathtub washing our dogs because they'd gotten skunked."

Says the actor: "She was like, 'What?'"

"Yeah, she calls me [the Sexiest Man Alive] now," he adds. And who can blame her?

Her Alabama-bred heartthrob of a husband is also a sculptor who quotes Edgar Allan Poe, loves to give her massages and can't wait to start their family. "I'm ready; I think she's ready," Tatum, 32, says. "The first number that pops into my head is three, but I just want one to be healthy and then we'll see where we go after that."

"It’s really easy for us guys to say, 'I want like 15 kids,'" he continues. "Jenna will be like, 'Well you better get another wife!'"

Currently training to play an Olympic athlete in next year's Foxcatcher, Tatum is all heart and muscle at 195 pounds. "I like to be lean. If I get too bulky I can't move well and I like to move," he says. "When I'm not training, I get really round and soft."

Which is just fine by his wife. "People know him to be fun and sexy, but they don't know how emotionally deep and spiritually open he is," says Dewan-Tatum, 31. "He is such an open-hearted person; what you see is what you get."

For more of our exclusive interview and photos of Tatum – including more than 180 of your favorite sexiest men – pick up this week's issue of PEOPLE, on newsstands Friday

Read More..

Report: FDA wanted to close Mass pharmacy in 2003

WASHINGTON (AP) — Nearly a decade ago, federal health inspectors wanted to shut down the pharmacy linked to a recent deadly meningitis outbreak until it cleaned up its operations, according to congressional investigators.

About 440 people have been sickened by contaminated steroid shots distributed by New England Compounding Center, and more than 32 deaths have been reported since the outbreak began in September, according to the Centers for Disease Control and Prevention. That has put the Framingham, Mass.-based pharmacy at the center of congressional scrutiny and calls for greater regulation of compounding pharmacies, which make individualized medications for patients and have long operated in a legal gray area between state and federal laws.

The House Energy and Commerce Committee released a detailed history of NECC's regulatory troubles on Monday, ahead of a meeting Wednesday meeting to examine how the outbreak could have been prevented. The 25-page report summarizes and quotes from FDA and state inspection memos, though the committee declined to release the original documents.

The report shows that after several problematic incidents, Food and Drug Administration officials in 2003 suggested that the compounding pharmacy be "prohibited from manufacturing" until it improved its operations. But FDA regulators deferred to their counterparts in Massachusetts, who ultimately reached an agreement with the pharmacy to settle concerns about the quality of its prescription injections.

The congressional report also shows that in 2003 the FDA considered the company a pharmacy. That's significant because in recent weeks public health officials have charged that NECC was operating more as a manufacturer than a pharmacy, shipping thousands of doses of drugs to all 50 states instead of small batches of drugs to individual patients. Manufacturers are regulated by the FDA and are subject to stricter quality standards than pharmacies.

The report offers the most detailed account yet of the numerous regulatory complaints against the pharmacy, which nearly date back to its founding in 1998. Less than a year later, the company was cited by the state pharmacy board for providing doctors with blank prescription pads with NECC's information. Such promotional items are illegal in Massachusetts and the pharmacy's owner and director, Barry Cadden, received an informal reprimand, according to documents summarized by the committee.

Cadden was subject to several other complaints involving unprofessional conduct in coming years, but first came to the FDA's attention in 2002. Here are some key events from the report highlighting the company's early troubles with state and federal authorities:

__ In March of 2002 the FDA began investigating reports that five patients had become dizzy and short of breath after receiving NECC's compounded betamethasone repository injection, a steroid used to treat joint pain and arthritis that's different from the one linked to the current meningitis outbreak.

FDA inspectors visited NECC on April 9 and said Cadden was initially cooperative in turning over records about production of the drug. But during a second day of inspections, Cadden told officials "that he was no longer willing to provide us with any additional records," according to an FDA report cited by congressional investigators. The inspectors ultimately issued a report citing NECC for poor sterility and record-keeping practices but said that "this FDA investigation could not proceed to any definitive resolution," because of "problems/barriers that were encountered throughout the inspection."

__ In October of 2002, the FDA received new reports that two patients at a Rochester, N.Y., hospital came down with symptoms of bacterial meningitis after receiving a different NECC injection. The steroid, methylprednisolone acetate, is the same injectable linked to the current outbreak and is typically is used to treat back pain. Both patients were treated with antibiotics and eventually recovered, according to FDA documents cited by the committee.

When officials from the FDA and Massachusetts Board of Pharmacy visited NECC later in the month, Cadden said vials of the steroid returned by the hospital had tested negative for bacterial contamination. But when FDA scientists tested samples of the drug collected in New York they found bacterial contamination in four out of 14 vials sampled. It is not entirely clear whether FDA tested the same lot shipped to the Rochester hospital.

__ At a February 2003 meeting between state and federal officials, FDA staff emphasized "the potential for serious public consequences if NECC's compounding practices, in particular those relating to sterile products, are not improved." The agency issued a list of problems uncovered in its inspection to NECC, including a failure to verify if sterile drugs met safety standards.

But the agency decided to let Massachusetts officials take the lead in regulating the company, since pharmacies are typically regulated at the state level. It was decided that "the state would be in a better position to gain compliance or take regulatory action against NECC as necessary," according to a summary of the meeting quoted by investigators.

The FDA recommended the state subject NECC to a consent agreement, which would require the company to pass certain quality tests to continue operating. But congressional investigators say Massachusetts Board of Pharmacy did not take any action until "well over a year later."

__ In October 2004, the board sent a proposed consent agreement to Cadden, which would have included a formal reprimand and a three-year probationary period for the company's registration. The case ended without disciplinary action in 2006, when NECC agreed to a less severe consent decree with the state.

Massachusetts officials indicated Tuesday they are still investigating why NECC escaped the more severe penalty.

"I will not be satisfied until we know the full story behind this decision," the state's interim health commissioner Lauren Smith said in a transcript of her prepared testimony released a day ahead of delivery. Smith is one of several witnesses scheduled to testify Wednesday, including FDA Commissioner Margaret Hamburg.

The committee will also hear from the widow of 78-year-old Eddie C. Lovelace, a longtime circuit court judge in southern Kentucky. Autopsy results confirmed Lovelace received fungus-contaminated steroid injections that led to his death Sept. 17.

Joyce Lovelace will urge lawmakers to work together on legislation to stop future outbreaks caused by compounded drugs, according to a draft of her testimony.

"We now know that New England Compounding Pharmacy, Inc. killed Eddie. I have lost my soulmate and life's partner with whom I worked side by side, day after day for more than fifty years," Lovelace states.

Barry Cadden is also scheduled to appear at the hearing, after lawmakers issued a subpoena to compel him to attend.

The NECC has been closed since early last month, and Massachusetts officials have taken steps to permanently revoke its license. The pharmacy has recalled all the products it makes, including 17,700 single-dose vials of a steroid that tested positive for the fungus tied to the outbreak.

Read More..

2 LAPD officers guilty of perjury in drug case

Two Los Angeles Police Department officers lied under oath during a drug possession case four years ago, a Los Angeles County jury decided Tuesday.

The trial revolved around competing interpretations of a grainy, black and white video that the prosecution argued sharply contradicted sworn testimony from three officers regarding the discovery of cocaine. The video, the prosecution argued, showed the officers conspired to convict Guillermo Alarcon Jr. on drug charges.

"It's always tragic when police officers throw away their freedom and careers." LAPD Chief Charlie Beck said after the jury's verdict. "They lost sight of the fact that the ends never justify the means and that they must always police constitutionally… That is the great slippery slope of policing. It always has been and likely always will be."

As the verdict was read, former Officer Evan Samuel and suspended Officer Richard Amio showed no reaction. After the jury left the downtown Los Angeles courtroom, Samuel's mother blew her nose into a white tissue, her eyes filled with tears.

The jury found the two officers guilty on one count of conspiracy each and multiple counts of perjury. Samuel faces a maximum prison sentence of more than five years, while Amio faces more than four years.

Sentencing is scheduled for Dec. 12.

The jury deadlocked on conspiracy and perjury charges against a third officer, Manuel Ortiz, voting 11 to 1 for a guilty verdict. Judge Kathleen A. Kennedy declared a mistrial on those charges. Prosecutors have not yet decided whether to retry Ortiz, who has also been suspended.

Amio and Samuel testified in 2008 that while on patrol the previous year, they recognized Alarcon, a suspected gang member, in front of his East Hollywood apartment. The two officers said they chased him into the building's carport, where he threw a small black box against a trash bin. When it hit the ground, they said, the object cracked open and Samuel picked it up. Inside, they testified, they found rock and powder cocaine.

But in the video — which begins after Alarcon is in custody — officers search for more than 20 minutes before finding an object that prosecutors contended held the cocaine.

After the prolonged search, officers also appear to discuss opening the object and later say it contains cocaine.

Deputy Dist. Atty. Geoffrey Rendon told jurors during closing arguments that the officers conspired to deliver Alarcon to the court system "based on a set of lies."

The prosecution's key evidence was the video. At one point in the video, an officer tells another to "be creative in your writing," after the box was recovered, apparently alluding to an arrest report that would be written.

"Oh yeah, don't worry, sin duda ('no doubt')," comes the reply from another officer.

"The video," Rendon said, "doesn't lie."

Defense attorneys for the officers disputed that notion, saying the video didn't capture the entire story.

Attorney Ira Salzman, who represents Samuel, told jurors last week that the officers had already recovered the drugs when the video begins. The tape came from a security camera at the building managed by Alarcon's mother.

In the video, the officers were simply looking for additional evidence and the object recovered in the video was a piece broken off the black box that was recovered earlier, the defense argued.

Outside court Tuesday, Salzman said the video was either started too late or intentionally edited to obscure the portion where he said his client recovered the drugs.

But jurors rejected that argument.

"It just shows the power of video," Salzman said.

Outside of court, Alarcon's civil attorney Luis Carrillo hailed the verdict and said his client was not a gang member.

"It's a good day for justice all around the country," he said. "This verdict upholds the principle of equal justice under the law for everybody."

andrew.khouri@latimes.com

Times staff writer Joel Rubin contributed to this report.

Read More..

Afghan Warlord Ismail Khan’s Call to Arms Rattles Kabul

Bryan Denton for The New York Times

Mujahedeen commanders at a gathering in Herat, Afghanistan, to address the threat to security posed by the Taliban.

HERAT, Afghanistan — One of the most powerful mujahedeen commanders in Afghanistan, Ismail Khan, is calling on his followers to reorganize and defend the country against the Taliban as Western militaries withdraw, in a public demonstration of faltering confidence in the national government and the Western-built Afghan National Army.

Mr. Khan is one of the strongest of a group of warlords who defined the country’s recent history in battling the Soviets, the Taliban and one another, and who then were brought into President Hamid Karzai’s cabinet as a symbol of unity. Now, in announcing that he is remobilizing his forces, Mr. Khan has rankled Afghan officials and stoked fears that other regional and factional leaders will follow suit and rearm, weakening support for the government and increasing the likelihood of civil war.

This month, Mr. Khan rallied thousands of his supporters in the desert outside Herat, the cultured western provincial capital and the center of his power base, urging them to coordinate and reactivate their networks. And he has begun enlisting new recruits and organizing district command structures.

“We are responsible for maintaining security in our country and not letting Afghanistan be destroyed again,” Mr. Khan, the minister of energy and water, said at a news conference over the weekend at his office in Kabul. But after facing criticism, he took care not to frame his action as defying the government: “There are parts of the country where the government forces cannot operate, and in such areas the locals should step forward, take arms and defend the country.”

President Karzai and his aides, however, were not greeting it as an altruistic gesture. The governor of Herat Province called Mr. Khan’s reorganization an illegal challenge to the national security forces. And Mr. Karzai’s spokesman, Aimal Faizi, tersely criticized Mr. Khan.

“The remarks by Ismail Khan do not reflect the policies of the Afghan government,” Mr. Faizi said. “The government of Afghanistan and the Afghan people do not want any irresponsible armed grouping outside the legitimate security forces structures.”

In Kabul, Mr. Khan’s provocative actions have played out in the news media and brought a fierce reaction from some members of Parliament, who said the warlords were preparing to take advantage of the American troop withdrawal set for 2014.

“People like Ismail Khan smell blood,” Belqis Roshan, a senator from Farah Province, said in an interview. “They think that as soon as foreign forces leave Afghanistan, once again they will get the chance to start a civil war, and achieve their ominous goals of getting rich and terminating their local rivals.”

Indeed, Mr. Khan’s is not the only voice calling for a renewed alliance of the mujahedeen against the Taliban, and some of the others are just as familiar.

Marshal Muhammad Qasim Fahim, an ethnic Tajik commander who is President Karzai’s first vice president, said in a speech in September, “If the Afghan security forces are not able to wage this war, then call upon the mujahedeen.”

Another prominent mujahedeen fighter, Ahmad Zia Massoud, said in an interview at his home in Kabul that people were worried about what was going to happen after 2014, and he was telling his own followers to make preliminary preparations.

“They don’t want to be disgraced again,” Mr. Massoud said. “Everyone tries to have some sort of Plan B. Some people are on the verge of rearming.”

He pointed out that it was significant that the going market price of Kalashnikov assault rifles had risen to about $1,000, driven up by demand from a price of $300 a decade ago. “Every household wants to have an AK-47 at home,” he said.

“The mujahedeen come here to meet me,” Mr. Massoud added. “They tell me they are preparing. They are trying to find weapons. They come from villages, from the north of Afghanistan, even some people from the suburbs of Kabul, and say they are taking responsibility for providing private security in their neighborhood.”

Habib Zahori and Jawad Sukhanyar contributed reporting from Herat, Afghanistan, and an employee of The New York Times from Kabul.

Read More..

RIM to introduce new BlackBerry 10 devices on January 30

(Reuters) – Research In Motion Ltd plans to introduce its new line of BlackBerry 10 smartphones on January 30, the company said on Monday, giving investors a measure of confidence the long-awaited devices are approaching the finish line.

The Waterloo, Ontario-based company, a one-time pioneer in the smartphone industry, is betting its future on the new line of products, which will be powered by its new BlackBerry 10 operating system.

RIM has struggled over the last two years as its devices lost ground to snazzier and faster smartphones such as Apple Inc’s iPhone and Samsung Electronics Co Ltd‘s Galaxy line.

In a brief statement, RIM said the twice-delayed devices will be launched simultaneously in multiple countries. It will introduce two BlackBerry 10 smartphones, along with the platform that powers them at the event.

“While it is clearly an uphill battle for RIM given the recent launch of the iPhone 5 device and the aggressive marketing dollars being pushed toward Windows 8, we view it as a modest positive that a date is now officially set for the launch of the new BB10 devices,” Wells Fargo analyst Jennifer Fritzsche wrote in a note to clients.

RIM has said it plans initially to roll-out touchscreen devices. Phones with the mini QWERTY keyboards that many long-time BlackBerry users rave about will come a few weeks later, while lower-end versions of both devices will be launched later in the year.

The company did not say when the devices will be available in stores. That will be announced at the event.

Evercore Partners analyst Mark McKechnie believes the BB 10 devices will be available within two to four weeks of the launch event, but some such as Peter Misek of Jefferies expect the devices to go on sale only in March.

RIM’s Nasdaq-listed shares were up 3.2 percent at $ 8.82 in late afternoon trading on Monday. Its Toronto-listed shares rose nearly 3 percent to C$ 8.81.

ALL OR NOTHING

RIM says its new devices will be faster and smoother and have a large catalog of applications that are now crucial to the success of any new line of smartphones.

Last week, the new platform and devices won U.S. government security clearance, potentially allowing both U.S. and Canadian government agencies to deploy the new smartphones as soon as they are available.

These were the first BlackBerry products to win Federal Information Processing Standard 140-2 certifications ahead of their introduction, the company said.

RIM began carrier tests on the BB10 devices last month. The Canadian company hopes they will help it win back some of the market share it lost to the iPhone and devices that run on Google Inc’s Android operating system.

RIM’s stock has fallen more than 90 percent from a peak of over $ 148 in 2008. But at Friday’s close, the shares were up about 20 percent over the last two months on signs that the BlackBerry 10 devices are finally likely to make it to market.

(Reporting by Euan Rocha; Editing by Lisa Von Ahn, Janet Guttsman and Andre Grenon)

Gadgets News Headlines – Yahoo! News

Read More..

Selena Gomez Is All Smiles at Glamour's Women of the Year Awards

By Michelle Ward and Tim Nudd

11/13/2012 at 08:55 AM EST

Justin who?

Looking stylish and happy, Selena Gomez hardly seemed like someone who's just gone through a breakup as she lit up New York's Carnegie Hall on Monday night at Glamour's 2012 Women of the Year Awards.

Bieber, 18, was performing just across the East River in Brooklyn. But he seemed a world away, as a radiant Gomez, 20, gave a speech thanking Glamour for including her among its honorees, which also included Lena Dunham, Annie Leibovitz and the U.S. women's gymnastics team.

"I'm so honored to be in a room full of women I can only aspire to be as good as one day," Gomez said. "I feel so lucky that every day I get to work with interesting people that are way smarter than me and have taught me so much."

The actress-singer also thanked her mom, who was in the audience.

"I just want to share this with all the girls out there," she said. "You have a voice. You have a chance to just do what you love, whether that's acting or singing and just being true to who you are. And the person that's taught me that is my mom."

Bieber, meanwhile, blazed through a 20-song show at the Barclays Center. But unlike Saturday in Boston, he didn't sing Justin Timberlake's hit "Cry Me a River," which some thought may have been a dig at his ex.

Read More..

British medical journal slams Roche on Tamiflu

LONDON (AP) — A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.

The drug has been stockpiled by dozens of governments worldwide in case of a global flu outbreak and was widely used during the 2009 swine flu pandemic.

On Monday, one of the researchers linked to the BMJ journal called for European governments to sue Roche.

"I suggest we boycott Roche's products until they publish missing Tamiflu data," wrote Peter Gotzsche, leader of the Nordic Cochrane Centre in Copenhagen. He said governments should take legal action against Roche to get the money back that was "needlessly" spent on stockpiling Tamiflu.

Last year, Tamiflu was included in a list of "essential medicines" by the World Health Organization, a list that often prompts governments or donor agencies to buy the drug.

Tamiflu is used to treat both seasonal flu and new flu viruses like bird flu or swine flu. WHO spokesman Gregory Hartl said the agency had enough proof to warrant its use for unusual influenza viruses, like bird flu.

"We do have substantive evidence it can stop or hinder progression to severe disease like pneumonia," he said.

In the U.S., the Centers for Disease Control and Prevention recommends Tamiflu as one of two medications for treating regular flu. The other is GlaxoSmithKline's Relenza. The CDC says such antivirals can shorten the duration of symptoms and reduce the risk of complications and hospitalization.

In 2009, the BMJ and researchers at the Nordic Cochrane Centre asked Roche to make all its Tamiflu data available. At the time, Cochrane Centre scientists were commissioned by Britain to evaluate flu drugs. They found no proof that Tamiflu reduced the number of complications in people with influenza.

"Despite a public promise to release (internal company reports) for each (Tamiflu) trial...Roche has stonewalled," BMJ editor Fiona Godlee wrote in an editorial last month.

In a statement, Roche said it had complied with all legal requirements on publishing data and provided Gotzsche and his colleagues with 3,200 pages of information to answer their questions.

"Roche has made full clinical study data ... available to national health authorities according to their various requirements, so they can conduct their own analyses," the company said.

Roche says it doesn't usually release patient-level data available due to legal or confidentiality constraints. It said it did not provide the requested data to the scientists because they refused to sign a confidentiality agreement.

Roche is also being investigated by the European Medicines Agency for not properly reporting side effects, including possible deaths, for 19 drugs including Tamiflu that were used in about 80,000 patients in the U.S.

____

Online:

www.bmj.com.tamiflu/

Read More..